Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 50S ribosomal subunit is the larger component of the prokaryotic 70S ribosome, serving as the site for peptide bond formation and protein elongation (Wilson, 2014, Nature Reviews Microbiology). Within this subunit, the peptidyl transferase center (PTC) acts as a ribozyme to catalyze the reaction between the growing peptide chain and incoming amino acids (Dunkle et al., 2010, PNAS). Adjacent to the PTC is the nascent polypeptide exit tunnel (NPET), a long, narrow passage through which the newly synthesized protein travels to reach the exterior of the ribosome. These regions are critical therapeutic targets for a wide range of antibiotics, including macrolides, lincosamides, oxazolidinones, and pleuromutilins (Arenz & Wilson, 2016, Cold Spring Harbor Perspectives in Medicine). Macrolides typically bind within the NPET to physically block the progression of the nascent peptide, leading to premature peptidyl-tRNA dissociation. In contrast, drugs like chloramphenicol and oxazolidinones bind at or near the PTC to directly interfere with the positioning of tRNA substrates or the catalytic process itself. Because these sites are composed primarily of highly conserved 23S ribosomal RNA, they are essential for bacterial survival across many species. However, the structural similarity between bacterial ribosomes and human mitochondrial ribosomes can lead to off-target toxicity, such as myelosuppression or neuropathy during prolonged treatment. Resistance is a significant clinical challenge, often mediated by rRNA methylation or mutations that alter the drug-binding pocket.
Inhibition of bacterial protein synthesis by physically blocking the nascent polypeptide exit tunnel or interfering with the catalytic activity of the peptidyl transferase center.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 50S ribosomal subunit peptidyl transferase center and exit tunnel (50S PTC/NPET).